Table 2.

Effect of ASA (25 mg·kg⁻¹ per os, bid) with and without rofecoxib cotreatment (25 mg·kg⁻¹ per os, bid) on the incidence of thrombotic events (cyclic flow variations, CFVs; occluding thrombi, OT) after mechanical injury plus stenosis of the carotid artery in rabbits on standard (standard) or cholesterol-enriched (Chol) diet

			Thrombotic events [n]
Diet	Treatment	n	CFVs	OT	None	[%]
Standard	None	11	3	8	0	100
Chol	None	13	5	8	0	100
Chol	Rofecoxib	6	4	3	0	100
Chol	ASA	8	2	1	5	38*
Chol	ASA + rofecoxib	5	1	3	1	80

^*P < 0.05 (treatment vs. no treatment).